Recent clinical trials of proprotein convertase subtilisin-kexin (PCSK) type 9 inhibitors in coronary artery disease

Research output: Contribution to journal › Editorial › peer-review

ASJC Scopus subject areas

@article{b44c8d0314684031aca05cd6b78f1719,

title = "Recent clinical trials of proprotein convertase subtilisin-kexin (PCSK) type 9 inhibitors in coronary artery disease",

author = "Viola Mechirova and Singh, \{R. B.\} and Ludovit Gaspar and Ernest Adeghate and Galal Elkilany and Jaipaul Singh",

year = "2017",

language = "English",

volume = "9",

pages = "15--18",

journal = "World Heart Journal",

issn = "1556-4002",

publisher = "Nova Science Publishers, Inc.",

number = "1",

}

TY - JOUR

T1 - Recent clinical trials of proprotein convertase subtilisin-kexin (PCSK) type 9 inhibitors in coronary artery disease

AU - Mechirova, Viola

AU - Singh, R. B.

AU - Gaspar, Ludovit

AU - Adeghate, Ernest

AU - Elkilany, Galal

AU - Singh, Jaipaul

PY - 2017

Y1 - 2017

UR - https://www.scopus.com/pages/publications/85027337110

UR - https://www.scopus.com/pages/publications/85027337110#tab=citedBy

M3 - Editorial

AN - SCOPUS:85027337110

SN - 1556-4002

VL - 9

SP - 15

EP - 18

JO - World Heart Journal

JF - World Heart Journal

IS - 1

ER -